home / stock / vxrt / vxrt news


VXRT News and Press, Vaxart Inc. From 04/17/20

Stock Information

Company Name: Vaxart Inc.
Stock Symbol: VXRT
Market: NASDAQ
Website: vaxart.com

Menu

VXRT VXRT Quote VXRT Short VXRT News VXRT Articles VXRT Message Board
Get VXRT Alerts

News, Short Squeeze, Breakout and More Instantly...

VXRT - APT, PTON among premarket losers

Pulmatrix (NASDAQ: PULM )  -27%  on $8M direct offering . More news on: Pulmatrix, Inc., Moleculin Biotech, Inc., Cutera, Inc., Stocks on the move, , Read more ...

VXRT - HAL and APA among premarket gainers

SG Blocks (NASDAQ: SGBX ) +100%  on Q4 results .. More news on: SG Blocks, Inc., EyeGate Pharmaceuticals, Inc., Kiniksa Pharmaceuticals, Ltd., Stocks on the move, , Read more ...

VXRT - Vaxart Provides Update on its Oral COVID-19 Vaccine Program

Five COVID-19 Vaccine Candidates in Preclinical Testing Development Services to Enable Manufacture of cGMP Vaccine at Emergent BioSolutions have Started SOUTH SAN FRANCISCO, Calif., March 31, 2020 (GLOBE NEWSWIRE) -- Vaxart, Inc., a clinical-stage biotechnology company developing...

VXRT - Vaxart's Coronavirus Stock Bump Is Unlikely To Continue So Exit Now Or Be Very Long

Vaxart, Inc ( VXRT ) is a clinical stage biotech company developing vaccines taken orally by tablet instead of by injection. Vaxart is currently working with Emergent BioSolutions (EBS) to develop a potential coronavirus (Covid-19) vaccine. A clinical study is scheduled to begin sometime in ...

VXRT - Identifying the Significant Differences Among Head-Start Candidates in Race for Coronavirus Vaccine

Biotech Insider – Time is of the essence, as the race for a vaccine to curb the spread of the coronavirus (COVID-19) pandemic is underway. While human trials began last week for the first doses of an experimental COVID-19 vaccine, experts from the World Health Organization are real...

VXRT - Vaxart Announces Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate Update

Company Focuses on COVID-19 Program, the First Oral Coronavirus Vaccine Raised total of $19.8 Million from a Registered Direct Offering and Warrant Exercises during Q1 2020 SOUTH SAN FRANCISCO, Calif., March 19, 2020 (GLOBE NEWSWIRE) -- Vaxart, Inc., a clinical-stage biotechnology...

VXRT - Profit-taking pressures Moderna after Hahn comments on vaccine timeline

Moderna ( MRNA -15.9% ) slumps on more than double normal volume on the heels of comments today from FDA Commissioner Stephen Hahn (during the Coronavirus Task Force briefing) that approval of a COVID-19 vaccine is at least a year away which is consistent with health authorities' expecta...

VXRT - What Are The Best Penny Stocks? 3 To Watch Right Now

Penny Stocks To Buy [or avoid] After Coronavirus Cases Top 200k The novel coronavirus has turned the market on its head. World governments are scrambling to figure out what to do next. Current remedies include city-wide shutdowns, school closures, event closures, and even an end to sports for ...

VXRT - SLS, APRN among premarket gainers

Biomerica (NASDAQ: BMRA ) +133%  on advancement of rapid coronavirus test. More news on: Biomerica, Inc., IMV Inc., Vaxart, Inc., Stocks on the move, , Read more ...

VXRT - Vaxart up 64% premarket on coronavirus vaccine deal

Vaxart (NASDAQ: VXRT ) jumps  64%  premarket on robust volume in reaction to its agreement with Emergent BioSolutions (NYSE: EBS ) under which the latter will deploy its molecule-to-market contract development and manufacturing services for Vaxart's COVID-19 oral vaccine candidat...

Previous 10 Next 10